Search research articles
Contact Us
Filters
Showing results (301-310 of 387) with videos related to
Page
of 39
Sort By:
The Journal of Allergy and Clinical Immunology
|
July 30, 2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B Pavel, Teresa Song, Hyun-Je Kim, et al.
The Journal of Investigative Dermatology
|
April 24, 2009
Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation
Mark J Bluth, Lisa C Zaba, Dariush Moussai, et al.
Experimental Dermatology
|
October 28, 2020
The erythema Q-score, an imaging biomarker for redness in skin inflammation
John Frew, Lauren Penzi, Mayte Suarez-Farinas, et al.
Journal of the American Academy of Dermatology
|
February 8, 2018
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
Emma Guttman-Yassky, Jonathan I Silverberg, Osamu Nemoto, et al.
Allergy
|
February 20, 2024
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities
Ester Del Duca, Dante Dahabreh, Madeline Kim, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Allergy
|
October 22, 2022
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
Yael Renert-Yuval, Ana B Pavel, Ester Del Duca, et al.
Allergy
|
November 29, 2022
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases
Carlos J Aranda, Edgar Gonzalez-Kozlova, Sean P Saunders, et al.
American Journal of Clinical Dermatology
|
May 14, 2022
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Andrew Blauvelt, Emma Guttman-Yassky, Amy S Paller, et al.
Journal of the American Academy of Dermatology
|
December 4, 2023
Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa
Kristina Navrazhina, Yael Renert-Yuval, Saakshi Khattri, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 387) with videos related to
Sort By:
Page
of 39
The Journal of Allergy and Clinical Immunology
|
July 30, 2019
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B Pavel, Teresa Song, Hyun-Je Kim, et al.
The Journal of Investigative Dermatology
|
April 24, 2009
Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation
Mark J Bluth, Lisa C Zaba, Dariush Moussai, et al.
Experimental Dermatology
|
October 28, 2020
The erythema Q-score, an imaging biomarker for redness in skin inflammation
John Frew, Lauren Penzi, Mayte Suarez-Farinas, et al.
Journal of the American Academy of Dermatology
|
February 8, 2018
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
Emma Guttman-Yassky, Jonathan I Silverberg, Osamu Nemoto, et al.
Allergy
|
February 20, 2024
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities
Ester Del Duca, Dante Dahabreh, Madeline Kim, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Allergy
|
October 22, 2022
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
Yael Renert-Yuval, Ana B Pavel, Ester Del Duca, et al.
Allergy
|
November 29, 2022
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases
Carlos J Aranda, Edgar Gonzalez-Kozlova, Sean P Saunders, et al.
American Journal of Clinical Dermatology
|
May 14, 2022
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Andrew Blauvelt, Emma Guttman-Yassky, Amy S Paller, et al.
Journal of the American Academy of Dermatology
|
December 4, 2023
Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa
Kristina Navrazhina, Yael Renert-Yuval, Saakshi Khattri, et al.
Page
of 39